Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Matrixx Initiatives, Inc., manufacturer and marketer of Zicam®, leading provider of over-the-counter homeopathic cold shortening products, today...
Zicam®, a leading provider of over-the-counter homeopathic cold shortening, allergy relief and allopathic nasal congestion products, today announced...
Zicam®, a leading provider of over-the-counter homeopathic cold and allergy relief products, today announced the release of the completely...
Zicam®, a leading provider of over-the-counter cold and allergy relief products, today kicks off National Immunity Month with the launch of Zicam®...
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has withdrawn the $1.60 per...
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, today announced that it has filed a presentation with...
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has increased its offer to...
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, is proud to announce the appointment of pioneering...
Matrixx Initiatives, Inc. today announced that the Superior Court of the State of Arizona in and for the County of Maricopa entered an order setting...
Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company"), an over-the-counter healthcare company that develops and markets Zicam®...
Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced financial ...
Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm,...
Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") and H.I.G. Capital, LLC, a leading global private investment firm, today...
Matrixx Initiatives, Inc. (Nasdaq: MTXX) ("Matrixx" or the "Company") today announced that it has entered into a definitive merger agreement to be...
Matrixx Initiatives, Inc. (Nasdaq: MTXX) and Lead Plaintiffs' Counsel in the Federal Multi-District Litigation in the District of Arizona and the...
Matrixx Initiatives, Inc., makers of Zicam, today announced a partnership with noted health expert Dr. Andrea Pennington to help educate consumers on ...
A new national survey of U.S. adults has found the majority of Americans are misinformed about what causes the common cold, and how and when they...
Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 second...
Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 first...
Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced that...
Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products that provide consumers...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.